Induction chemotherapy (ICT) is an attractive option for advanced head and neck squamous cell carcinoma (HNSCC) patients which has been prospectively evaluated in the context of a multimodality treatment approach. The theoretical benefit is the ability to suppress distant metastases and shrink the tumor while chemotherapy is better tolerated when given sequentially than concurrently. However, clinical trials have failed to show consistent benefit of ICT over concurrent radio-chemotherapy and due to so far lacking level 1 evidence ICT outside larynx organ preservation remains rather investigational. Immune modulation by inhibition of immune checkpoints is an exciting recent development in HNSCC which has mainly been investigated as second li...
Purpose: Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent c...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Head and neck cancers (HNC) represent a heterogeneous cluster of aggressive malignancies that accoun...
Induction chemotherapy (ICT) is an attractive option for advanced head and neck squamous cell carcin...
BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of r...
Background:Objective of current study was to observe the local control, progression free survival an...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
International audienceFive hundred and fifty thousand new head and neck cancer cases are diagnosed e...
Recently, considerable progress has been achieved in cancer immunotherapy. Targeted immune checkpoin...
International audienceNeoadjuvant chemotherapies for patients with advanced head and neck squamous c...
AIM: The purpose of the study was to assess outcomes of locally advanced head and neck (LAHNC) treat...
Background: Platinum-based chemoradiation (CCRT) is the standard treatment for Locally Advanced Head...
Head and neck squamous cell carcinoma (HNSCC) is a frequent tumour arising from multiple anatomical ...
Induction chemotherapy (ICT) is a controversial treatment for head and neck squamous cell carcinomas...
BackgroundAlthough induction chemotherapy can reduce distant metastases in locally advanced head and...
Purpose: Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent c...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Head and neck cancers (HNC) represent a heterogeneous cluster of aggressive malignancies that accoun...
Induction chemotherapy (ICT) is an attractive option for advanced head and neck squamous cell carcin...
BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of r...
Background:Objective of current study was to observe the local control, progression free survival an...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
International audienceFive hundred and fifty thousand new head and neck cancer cases are diagnosed e...
Recently, considerable progress has been achieved in cancer immunotherapy. Targeted immune checkpoin...
International audienceNeoadjuvant chemotherapies for patients with advanced head and neck squamous c...
AIM: The purpose of the study was to assess outcomes of locally advanced head and neck (LAHNC) treat...
Background: Platinum-based chemoradiation (CCRT) is the standard treatment for Locally Advanced Head...
Head and neck squamous cell carcinoma (HNSCC) is a frequent tumour arising from multiple anatomical ...
Induction chemotherapy (ICT) is a controversial treatment for head and neck squamous cell carcinomas...
BackgroundAlthough induction chemotherapy can reduce distant metastases in locally advanced head and...
Purpose: Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent c...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Head and neck cancers (HNC) represent a heterogeneous cluster of aggressive malignancies that accoun...